GATC to Provide Access to Qiagen's NGS Data Analysis Solution | GenomeWeb

NEW YORK (GenomeWeb) – GATC Biotech will offer its clients full access to Qiagen's Ingenuity Variant Analysis solution under a non-exclusive deal announced today by Qiagen. 

Under the terms of the deal, GATC clients will also have access to interpretation services. Ingenuity Variant Analysis is a bioinformatics platform that enables laboratories to evaluate data generated by high-throughput next-generation sequencing technologies. It filters genetic variants in a cloud-based environment to identify those most likely to cause disease. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.